Advanced Medical Solutions Group (LON:AMS) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 213.89 and traded as low as GBX 212. Advanced Medical Solutions Group shares last traded at GBX 217, with a volume of 668,568 shares.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a report on Thursday, January 15th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Price Performance

The business’s 50-day simple moving average is GBX 216.67 and its two-hundred day simple moving average is GBX 213.89. The stock has a market cap of £469.56 million, a price-to-earnings ratio of 52.04, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.